$APT Balance Sheet | Understand Stock

$APT

$5.44 -$0.12 (2.16%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Cash and cash equivalents
Accounts receivable
Nonrelated Party
Related Party
Total accounts receivable

Accounts receivable, related party
Inventories, net
Prepaid expenses
Total current assets
Property and equipment, net
Goodwill
Definite-lived intangible assets, net
Right-of-use assets
Equity investment in unconsolidated affiliate
Total assets

Current liabilities:
Accounts payable
Accrued liabilities
Customer advance payments of orders
Lease liabilities
Total current liabilities
Lease liabilities, net of current portion
Deferred income tax liabilities, net
Total liabilities

Shareholders' equity:
Common stock, $.01 par value: 50,000,000 shares authorized; 10,120,851 and 10,131,565 shares outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total shareholders' equity
Total liabilities and shareholders' equity

Comments